Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson’s Disease-Reference-Cited by-同舟云学术

Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson’s Disease

Published:2017-08-08 Issue:3 Volume:7 Page:491-501
ISSN:1877-7171
Container-title:Journal of Parkinson's Disease
language:
Short-container-title:JPD

Author:

Fabbri Margherita¹,Reimão Sofia¹²,Carvalho Miguel³,Nunes Rita G.³⁴,Abreu Daisy¹,Guedes Leonor Correia¹⁵,Bouça Raquel¹,Lobo Patricia P.¹,Godinho Catarina¹⁶⁷,Coelho Miguel¹⁵,Gonçalves Nilza C.¹,Rosa Mario Miguel¹⁵,Antonini Angelo⁸,Ferreira Joaquim J.¹⁷⁹

Affiliation:

1. Clinical Pharmacology Unit, Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon, Lisbon, Portugal

2. Department of Neurological Imaging, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon, Portugal

3. Instituto de Biofísica e Engenharia Biomédica, Faculdade de Ciências, University of Lisbon, Lisbon, Portugal

4. Department of Bioengineering and Institute for Systems and Robotics (LARSyS), Instituto Superior Técnico, University of Lisbon, Lisbon, Portugal

5. Department of Neurosciences, Hospital Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon, Portugal

6. Center for Interdisciplinary Research Egas Moniz(CiiEM), Instituto Superior de Ciências da Saúde EgasMoniz, Monte de Caparica, Portugal

7. CNS – Campus Neurológico Sénior, Torres Vedras, Portugal

8. Fondazione Ospedale San Camillo”-I.R.C.C.S., Parkinson and Movement Disorders Unit, Venice, Italy

9. Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Reference39 articles.

1. Milestones in Parkinson’s disease–clinical and pathologic features;Halliday;Mov Disord,2011

2. Iron-binding characteristics of neuromelanin of the human substantia nigra;Double;Biochem Pharmacol,2003

3. Ageing and Parkinson’s disease: Substantia nigra regional selectivity;Fearnley;Brain,1991

4. Disease duration and theintegrity of the nigrostriatal system in Parkinson’s disease;Kordower;Brain,2013

5. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson’s disease;Gibb;J Neurol Neurosurg Psychiatry,1991

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A more objective PD diagnostic model: integrating texture feature markers of cerebellar gray matter and white matter through machine learning;Frontiers in Aging Neuroscience;2024-06-07

2. Regional nigral neuromelanin degeneration in asymptomatic leucine-rich repeat kinase 2 gene carrier using MRI;Scientific Reports;2024-05-09

3. PENCIL imaging: A novel approach for neuromelanin sensitive MRI in Parkinson's disease;NeuroImage;2024-05

4. The neurobiological effects of senescence on dopaminergic system: A comprehensive review;Journal of Chemical Neuroanatomy;2024-04

5. Neuromelanin‐sensitive magnetic resonance imaging: Possibilities and promises as an imaging biomarker for Parkinson's disease;European Journal of Neuroscience;2024-03-05